Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

Nature Genetics

Volumn 31, Issue 4, 2002, Pages 429-434

  Martin, Maureen P ^a   Gao, Xiaojiang ^a   Lee, Jeong Hee ^b,h   Nelson, George W ^a   Detels, Roger ^c   Goedert, James J ^b   Buchbinder, Susan ^d   Hoots, Keith ^e   Vlahov, David ^f   Trowsdale, John ^g   Wilson, Michael ^g,i   O’Brien, Stephen J ^b   Carrington, Mary ^a  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d San Francisco City Clinic Cohort   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h Gyeongsang National University   (South Korea)

ⁱ GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; IMMUNOGLOBULIN RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE COURSE; EPISTASIS; GENE LOCUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TARGET CELL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; CD4-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; EPISTASIS, GENETIC; EPITOPES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HIV-1; HLA-B ANTIGENS; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC; REGRESSION ANALYSIS; SURVIVAL RATE; UNITED STATES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036699528     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng934     Document Type: Article

References (30)

1. Lanier, L.L. NK cell receptors. Annu. Rev. Immunol. 16, 359-393 (1998).
2. Long, E.O. & Rajagopalan, S. HLA class I recognition by killer cell Ig-like receptors. Semin. Immunol. 12, 101-108 (2000).
3. Lorenzo, M.E., Ploegh, H.L. & Tirabassi, R.S. Viral immune evasion strategies and the underlying cell biology. Semin. Immunol. 13, 1-9 (2001).
4. Collins, K.L., Chen, B.K., Kalams, S.A., Walker, B.D. & Baltimore, D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397-401 (1998).
5. Trowsdale, J. et al. The genomic context of natural killer receptor extended gene families. Immunol. Rev. 181, 20-38 (2001).
6. Wilson, M.J. et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc. Natl Acad. Sci. USA 97, 4778-4783 (2000).
7. Rojo, S., Wagtmann, N. & Long, E.O. Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101; requirement for all three p70 immunoglobulin domains. Eur. J. Immunol. 27, 568-571 (1997).
8. Gardiner, C.M. et al. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J. Immunol. 166, 2992-3001 (2001).
9. Long, E.O. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17, 875-904 (1999).
10. Lanier, L.L., Corliss, B.C., Wu, J., Leong, C. & Phillips, J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391, 703-707 (1998).
11. Biassoni, R. et al. The human leukocyte antigen (HLA)-C-specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183, 645-650 (1996).
12. Muller, C.A. et al. Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6. Immunogenetics 30, 200-207 (1989).
13. Gumperz, J.E., Litwin, V., Phillips, J.H., Lanier, L.L. & Parham, P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181, 1133-1144 (1995).
14. Cella, M., Longo, A., Ferrara, G.B., Strominger, J.L. & Colonna, M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J. Exp. Med. 180, 1235-1242 (1994).
15. Gumperz, J.E. et al. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J. Immunol. 158, 5237-5241 (1997).
16. McMichael, A.J. & Rowland-Jones, S.L. Cellular immune responses to HIV. Nature 410, 980-987 (2001).
17. Carrington, M., Nelson, G. & O'Brien, S.J. Considering genetic profiles in functional studies of immune responsiveness to HIV-1. Immunol. Lett. 79, 131-140 (2001).
18. Kaslow, R.A. et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med. 2, 405-411 (1996).
19. Gao, X. et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N. Engl. J. Med. 344, 1668-1675 (2001).
20. Flores-Villanueva, P.O. et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc. Natl Acad. Sci. USA 98, 5140-5145 (2001).
21. O'Brien, S.J., Gao, X. & Carrington, M. HLA and AIDS: a cautionary tale. Trends Mol. Med. 7, 379-381 (2001).
22. Colonna, M., Brooks, E.G., Falco, M., Ferrara, G.B. & Strominger, J.L. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 260, 1121-1124 (1993).
23. Boyington, J.C., Brooks, A.G. & Sun, P.D. Structure of killer cell immunoglobulin-like receptors and their recognition of the class I MHC molecules. Immunol. Rev. 181, 66-78 (2001).
24. Phillips, J.H., Gumperz, J.E., Parham, P. & Lanier, L.L. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268, 403-405 (1995).
25. De Maria, A. et al. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. Proc. Natl Acad. Sci. USA 94, 10285-10288 (1997).
26. Koup, R.A. et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68, 4650-4655 (1994).
27. Kelleher, A.D. et al. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med. 193, 375-386 (2001).
28. Hughes, A.L., Yeager, M. & Carrington, M. Peptide binding function and the paradox of HLA disease associations. Immunol. Cell. Biol. 74, 444-448 (1996).
29. Peruzzi, M., Wagtmann, N. & Long, E.O. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA*B*2705. J. Exp. Med. 184, 1585-1590 (1996).
30. Kajiwara, K., Berson, E.L. & Dryja, T.P. Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science 264, 1604-1608 (1994).